TN

Thomas Needham

Biotech VC Investor | Broadview Ventures | Longview Ventures

Greater Boston

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Managing Director

    2025

    Managing Director of Longview Ventures, an independent investment vehicle focused on clinical-stage opportunities, as a complement to Broadview's dedication to Seed and Series A financings.

  • Director, Head of BioPharma

    2019 - 2025

  • Director, Head of BioPharma

    2018

    Head of the BioPharmaceuticals practice managing the firm's biotechnology investment strategy and activity, from identification and screening of new opportunities, through due diligence, deal structure and syndication, portfolio company board management roles and overarching portfolio strategy.

  • Board Observer

    2024

2024

  • Board of Directors, Member

    2024

  • Board of Directors, Member

    2023

  • Chairman, Board of Directors

    2020 - 2023

  • Board Observer

    2021

  • Board Observer

    2020

2020 - 2024

  • Board Observer

    2023 - 2024

  • Board of Directors, Member

    2020 - 2023

2019 - 2022

  • Board of Directors, Member

    2021 - 2022

  • Chairman, Board of Directors

    2019 - 2021

    Renovacor (NYSE: RCOR) acquired by Rocket Pharmaceuticals (Nasdaq: ROCK)

2018 - 2022

  • Board of Directors, Member

    2021 - 2022

  • Board Observer

    2018 - 2021